Sensei Biotherapeutics
SNSE
trading on NASDAQ
since 2021
$10.35
(Δ 38.24%)
+$2.86 since open
Sensei Biotherapeutics is a biotechnology company focused on developing innovative cancer immunotherapies that combine immune cell engineering with proprietary technologies to create targeted and potent treatments designed to empower the immune system to fight cancer effectively.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.48 | $10.99 | $7.37 | $9.43M | 213.37K |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.27 | n/a | +Inf | -Inf% | -Inf% | 0% |